Wayne State University School of Medicine

Samaritas to Celebrate the Vibrant Culture of Refugees at the Lavish Ripples Gala on Nov. 3

Retrieved on: 
Monday, October 9, 2023
St Mary Abbots, Health, MDHHS, News, Delta Dental, Organization, Perseverance, University, Disability studies, Wayne, Lieutenant, KTVI, Addiction, Difference, Assistant, Refugee, FOX, Child, Wayne State University School of Medicine, Sale, Drug, Nursing, Samaritas

DETROIT, Oct. 9, 2023 /PRNewswire/ -- Samaritas, one of Michigan's largest health and human service organizations, will host the Ripples Gala presented by Delta Dental on Friday, Nov. 3, at the MotorCity Hotel .

Key Points: 
  • DETROIT, Oct. 9, 2023 /PRNewswire/ -- Samaritas, one of Michigan's largest health and human service organizations, will host the Ripples Gala presented by Delta Dental on Friday, Nov. 3, at the MotorCity Hotel .
  • John Laing will receive the Outstanding Service Award and Kensington Church will be honored with the Samaritas Great Ambassador award.
  • "Samaritas serves as a safe haven for so many people who can't always fend for themselves," said Dave Morin, CEO of Samaritas.
  • Each story will underscore the need for Samaritas and more advocacy to improve the child welfare system and reform immigration policies.

Cellarity Appoints Dr. Gregory J. Moore to Board of Directors

Retrieved on: 
Tuesday, June 6, 2023
Health, Other Health, Other Science, Research, Science, Pharmaceutical, Biotechnology, Cloud, Interim, Therapy, Pharming, Medical imaging, Radiology, Biomedical Research, Geisinger Health System, Microsoft, Global health, Health informatics, Wayne State University School of Medicine, Stanford University School of Medicine, Acquisition, Flagship Pioneering, Patient, Machine learning, Engineering, Neuroradiology, Informatics, Corporation, Biology, AI, Ecosystem, NYSE, Disease, Penn State University College of Medicine, Medical device, Zasmidium cellare, Nuance

Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced today the appointment of Gregory J. Moore, M.D., Ph.D., to the Company’s Board of Directors.

Key Points: 
  • Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced today the appointment of Gregory J. Moore, M.D., Ph.D., to the Company’s Board of Directors.
  • “Greg is an industry leader, driving technology and life sciences innovation at the intersection of medical and large-scale computation,” said Stephen Berenson, Chairman of Cellarity’s Board of Directors and Managing Partner at Flagship Pioneering.
  • Dr. Moore is board certified in Diagnostic Radiology, Neuroradiology, and Clinical Informatics.
  • He currently serves as an independent director on the boards of DaVita (NYSE:DVA) and Olink Holding AB (NASDAQ:OLK).

The Inner Circle Acknowledges, Mufid N. Khoury, MD as a Exceptional Healthcare Professional for his contributions to the Healthcare Field as a Hospitalist

Retrieved on: 
Monday, April 17, 2023
Pneumonia, Hospital medicine, MI, Barbara Bates (American physician), Physician, University School, Splenic infarction, Medicine, Internship, Sepsis, Family medicine, Inner circle, Wayne State University School of Medicine, American Board of Family Medicine, American Board of Commissioners for Foreign Missions, MD, Patient, Wayne, Health, HonorHealth Scottsdale Osborn Medical Center, Family, Medical degree, Nursing, Medical device

SCOTTSDALE, Ariz., April 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Mufid N. Khoury, MD, is acknowledged as an Exceptional Healthcare Professional for his contributions to the Healthcare Field as a Hospitalist.

Key Points: 
  • SCOTTSDALE, Ariz., April 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Mufid N. Khoury, MD, is acknowledged as an Exceptional Healthcare Professional for his contributions to the Healthcare Field as a Hospitalist.
  • He completed his Medical Degree and Internship at Wayne State University School of Medicine.
  • The doctor then attended William Beaumont Hospital in Detroit, MI to complete a Family Medicine residency program.
  • Looking to the future, Dr. Khoury plans to continue his work as a hospitalist and take on new leadership roles in the coming years.

Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President

Retrieved on: 
Tuesday, March 14, 2023
UCLA School of Dentistry, Acquisition, UCLA, Therapy, Division, Dimension, Partnership, Mentorship, David Geffen School of Medicine at UCLA, Gene, Genetics, Haemophilia, Patient, Pediatrics, Biology, Metabolism, Rare, DSM-IV codes, University, CMO, Disease, Wayne State University School of Medicine, Medical genetics, OTC, Pharmaceutical industry, Nursing, Ultragenyx

NOVATO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced that Eric Crombez, M.D., has been promoted to chief medical officer and executive vice president effective May 1, 2023, succeeding Camille Bedrosian, M.D., who will remain with the company in a full-time strategic advisory role.

Key Points: 
  • NOVATO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced that Eric Crombez, M.D., has been promoted to chief medical officer and executive vice president effective May 1, 2023, succeeding Camille Bedrosian, M.D., who will remain with the company in a full-time strategic advisory role.
  • Dr. Crombez currently serves as Ultragenyx’s chief medical officer for gene therapy and inborn errors of metabolism.
  • “Eric has extensive expertise in the development and execution of clinical development programs for rare genetic disorders and has been a driving force for our entire gene therapy pipeline,” said Emil D. Kakkis, M.D., Ph.D., chief executive officer and president of Ultragenyx.
  • Dr. Crombez joined Ultragenyx following the acquisition of Dimension Therapeutics in November 2017.

Ellodi Pharmaceuticals Welcomes Debra Silberg MD, PhD, FACG to its Board of Directors

Retrieved on: 
Monday, February 27, 2023
Biotechnology, General Health, Pharmaceutical, Health, University, American College, Molecular biology, Doctor of Philosophy, FACG, Organization, Drug development, Partnership, FDA, BS, Albert Einstein College of Medicine, Patient, NDA, University of Pennsylvania Health System, Foundation for the National Institutes of Health, NIH, Division, Gastrointestinal disease, EMA, AstraZeneca, Eosinophilic esophagitis, Wayne State University School of Medicine, Medication, TPG Inc., American College of Gastroenterology, Bangladesh Technical Education Board, Physician, Pharmaceutical industry, MD, Gastroenterology, Takeda, Immunology

Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company dedicated to the continued development of APT-1011, a novel, investigational oral therapy for the treatment of Eosinophilic Esophagitis (EoE), announced today that Debra Silberg, MD, PhD, FACG has joined the company’s board of directors.

Key Points: 
  • Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company dedicated to the continued development of APT-1011, a novel, investigational oral therapy for the treatment of Eosinophilic Esophagitis (EoE), announced today that Debra Silberg, MD, PhD, FACG has joined the company’s board of directors.
  • Dr. Silberg is an accomplished life sciences executive with deep experience across all stages of drug development.
  • “This is an exciting time to be joining the Ellodi board," said Dr. Silberg.
  • The board will continue to provide guidance on the ongoing strategic direction of Ellodi Pharmaceuticals as it works towards the completion and commercialization of the APT-1011 development program.

Indaptus Therapeutics Names Robert Martell, M.D., Ph.D. to its Board of Directors

Retrieved on: 
Tuesday, February 14, 2023
Tufts Medical Center, Kalamazoo College, Big Pharma, Therapy, Pharmacology, Yale University, Development, Curie Institute (Paris), Wayne, Drug development, Research and development, Bayer, Patient, University, Doctor of Philosophy, Wayne State University School of Medicine, Duke University, Head, Chemistry, University School, Pharmaceutical industry, Nursing, Ageing, Research

NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announces it has named Robert Martell, M.D., Ph.D. to its Board of Directors.

Key Points: 
  • NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announces it has named Robert Martell, M.D., Ph.D. to its Board of Directors.
  • “Robert’s extensive industry experience and deep understanding of the issues associated with drug development, combined with his ongoing practice makes him an ideal board member for Indaptus.
  • I look forward to collaborating with him to help guide the Company toward continued success,” stated Roger Pomerantz, M.D., chairman of Indaptus Therapeutics’ Board of Directors.
  • “As a practicing physician with deep oncology experience, and a long-time veteran of the pharmaceutical industry, we believe Robert is an ideal addition to our Board of Directors,” commented Jeffrey Meckler, Indaptus Therapeutics’ Chief Executive Officer.

Open Book Extracts Appoints Andrea Baillo as Chief Scientific Officer to Lead Strategic Research Initiatives

Retrieved on: 
Wednesday, January 4, 2023
Quality of life, Dementia, OBX, Trial of the century, Wayne State University School of Medicine, History, Research and development, CBC, Baillo, GTI, CBN, Depression, Health, NSF, Partnership, Alzheimer's disease, Innovation, Research Triangle, FAMU, Harvard University, IP, Sleep, Safety, THCV, Acne, PTSD, Woman, R, CBDV, University of Colorado Boulder, Food, CGMP, Pain, Cannabinoid, Bipolar disorder, Science, Doctor of Philosophy, ISO, Case Western Reserve University School of Medicine, Clinical quality management system, Management, Fine chemical, Pharmaceutical industry, Cancer, Research

ROXBORO, N.C., Jan. 4, 2023 /PRNewswire/ -- Open Book Extracts (OBX), a leading ingredient manufacturer, product formulator, and manufacturer of the industry's most innovative and highest quality cannabinoid-enabled products, is pleased to announce the appointment of Andrea Baillo as Chief Scientific Officer. Andrea Baillo has broad research and innovation experience and will lead OBX's research and development (R&D) strategy.

Key Points: 
  • ROXBORO, N.C., Jan. 4, 2023 /PRNewswire/ -- Open Book Extracts (OBX), a leading ingredient manufacturer, product formulator, and manufacturer of the industry's most innovative and highest quality cannabinoid-enabled products, is pleased to announce the appointment of Andrea Baillo as Chief Scientific Officer.
  • Andrea Baillo has broad research and innovation experience and will lead OBX's research and development (R&D) strategy.
  • In her new role, Baillo will oversee all research and development efforts at OBX, including ingredient R&D, product development, and ingredient and product safety and efficacy research.
  • Baillo is an experienced scientist with a demonstrated history of working in cannabis research, development, and manufacturing, cancer research, and food and beverage industries.

Dr. Dominik Chrzan has joined with Castle Connolly to offer South Florida a new level of comprehensive primary care services and preventive medicine, medprevent premier

Retrieved on: 
Wednesday, December 28, 2022
Degenerative disease, Patient, Wayne, Communication, Obesity, Stress management, Partnership, American University, Diabetes, SENS, Fortis Healthcare, Therapy, Wayne State University School of Medicine, Liver disease, Physician, Research, Medical device, Pharmaceutical industry, Medicine, Exercise, Sleep

BOCA RATON, Fla., Dec. 28, 2022 /PRNewswire/ -- Castle Connolly Private Health Partners, LLC (CCPHP), a leader in redefining primary care, is pleased to announce the medprevent premier concierge medicine program, its collaboration with primary care and preventive medicine specialist Dr. Dominik Chrzan.

Key Points: 
  • Dr. Chrzan is known for providing a wide range of medical services with an emphasis on individualized care and wellness.
  • Through medprevent premier patients will experience the advantages of a high-touch care model coupled with Dr. Chrzan's personalized attention.
  • Through his partnership with CCPHP, Dr. Chrzan also has access to Castle Connolly's Top Doctor® Network of nearly 60,000 top recognized physicians nationwide.
  • In 2013, Dr. Chrzan moved to South Florida to pursue a career in primary care medicine and in 2015 started medprevent to focus on personalized primary care and preventive medicine.

Wayne State University receives $6 million grant from the Mellon Foundation to increase Black Studies faculty and establish the Detroit Center for Black Studies

Retrieved on: 
Tuesday, December 13, 2022
Faculty, Culture, Racism, Freedom, Mellon, Education, Pathway, School, Andrew W. Mellon Foundation, University of Michigan Detroit Center, Africana studies, Curriculum, Research, Knowledge, Mentorship, Imagination, Humanities, Wayne State University School of Medicine, Wayne, Multimedia, Wayne State University, Beauty, Student, Medicine, Pharmaceutical industry, Tutoring, Wayne State, Black

DETROIT, Dec. 13, 2022 /PRNewswire/ -- The Mellon Foundation awarded a $6 million grant to Wayne State University to launch a cluster hire program that will recruit and hire 30 new humanities faculty and create the Detroit Center for Black Studies.

Key Points: 
  • DETROIT, Dec. 13, 2022 /PRNewswire/ -- The Mellon Foundation awarded a $6 million grant to Wayne State University to launch a cluster hire program that will recruit and hire 30 new humanities faculty and create the Detroit Center for Black Studies.
  • The Mellon Foundation awarded a $6 million grant to Wayne State University to launch a cluster hire program that will recruit and hire 30 new humanities faculty and create the Detroit Center for Black Studies.
  • "We are grateful that the Mellon Foundation recognizes Wayne State's efforts to transform Black Studies at the university with this impactful support," said Wayne State Provost Mark Kornbluh.
  • A second initiative that the Mellon Foundation will support is the launch of the Detroit Center for Black Studies, a faculty-led multidisciplinary center at Wayne State that connects Black Studies faculty from institutions across the state of Michigan.

Karmanos Cancer Institute Receives the Women's Choice Award® as one of America's Best Hospitals for Cancer Care for 10th consecutive year

Retrieved on: 
Tuesday, December 6, 2022
Courage, Women's Choice Awards, Karmanos, Patient satisfaction, MSA, Hospital, Accreditation, Wayne State University School of Medicine, Karmanos Cancer Institute, McLaren Health Care Corporation, National Cancer Institute, Partnership, Patient, RN, Cancer, Karger Publishers, Research, Huntsman Cancer Institute, Breast cancer, Woman, Strathcona County, Health care, ACS, Wayne, Subclinical infection, Multimedia, Education, University School, Health, NCI, Medicine, Pharmaceutical industry

DETROIT, Dec. 6, 2022 /PRNewswire/ -- For the 10th consecutive year, the Barbara Ann Karmanos Cancer Institute has been named one of America's Best Hospitals for Cancer Care by the Women's Choice Award®, America's trusted referral source for the best in health care. The award signifies that Karmanos is in the top 10 percent of 4,729 U.S. hospitals offering cancer care services. Karmanos has received this honor since the inception of the award in 2014.

Key Points: 
  • DETROIT, Dec. 6, 2022 /PRNewswire/ -- For the 10th consecutive year,the Barbara Ann Karmanos Cancer Institute has been named one of America's Best Hospitals for Cancer Care by the Women's Choice Award , America's trusted referral source for the best in health care.
  • America's Best Hospitals for Cancer Care by the Women's Choice Award also ranked the NCI-designated comprehensive cancer center inthe topeight percentfor Breast Care and the topfive percentfor Mammogram Imaging.
  • Passi emphasized that Karmanos Cancer Institute and all the 2023 America's Best Hospitals for Cancer Care deliver the care that matters most to women.
  • The Barbara Ann Karmanos Cancer Institute is one of 459 award recipients representing the hospitals that have met the highest standards for cancer care inthe U.S.by the Women's Choice Award.